Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
choline alfoscerate + donepezil
- Development stage
- Unknown
- Lead developer
- Daewoong Bio
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Choline alfoscerate + donepezil is a fixed-dose combination therapy used in the management of Alzheimer's disease and cognitive impairment. Choline alfoscerate (also known as alpha-glycerylphosphorylcholine or α-GPC) is a phospholipid precursor that increases acetylcholine synthesis and release in the brain, supporting cholinergic neurotransmission. Donepezil is an acetylcholinesterase inhibitor that prevents the breakdown of acetylcholine, thereby enhancing cholinergic activity. The combination aims to provide synergistic effects by both increasing acetylcholine availability (via choline alfoscerate) and reducing its degradation (via donepezil). Clinical studies such as the ASCOMALVA trial have shown that this combination can slow cognitive decline more effectively than monotherapy with either agent alone in patients with Alzheimer's disease[1][3][4][5].
- Brand names
- AlfoatirinAripezil
- Other names
- alpha-glycerylphosphorylcholine + donepezilα-GPC + donepezilcholine alphoscerate + donepezil
02
Targets
Acetylcholinesterase
Beyond the preview
Go deeper on choline alfoscerate + donepezil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on choline alfoscerate + donepezil.